State of Tennessee, Department of Treasury
RAPP

State of Tennessee, Department of Treasury’s Rapport Therapeutics RAPP Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,400
Closed -$160K – 1812
2025
Q3 		$160K Buy
+5,400
New +$96.3K ﹤0.01% 1662

Other funds holding RAPP

TGV
TRV GP V Boston, Massachusetts $498M AUM 267.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

State of Tennessee, Department of Treasury's RAPP Position: Q4 2025 in Review

State of Tennessee, Department of Treasury sold out of Rapport Therapeutics (RAPP) in Q4 2025, closing a stake of 5,400 shares — an estimated $160K sold.

State of Tennessee, Department of Treasury first reported a position in RAPP in Q3 2025 and held it in 1 quarter. The position peaked at $160K in Q3 2025. 144 funds tracked by Wall St. Rank hold RAPP as of Q4 2025.

  • State of Tennessee, Department of Treasury reported no remaining Rapport Therapeutics position as of Q4 2025 after selling out during the quarter.
  • State of Tennessee, Department of Treasury sold 5,400 Rapport Therapeutics shares in Q4 2025, an estimated $160K.
  • State of Tennessee, Department of Treasury first reported a position in Rapport Therapeutics in Q3 2025 and held it in 1 quarter.
  • State of Tennessee, Department of Treasury's Rapport Therapeutics position peaked at $160K in Q3 2025.
  • 144 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q4 2025.

Based on State of Tennessee, Department of Treasury's 13F filing for Q4 2025, filed 18 Feb 2026.